205 related articles for article (PubMed ID: 36700503)
1. Risk of venous thromboembolism and bleeding after major surgery for ovarian cancer: standard in-hospital versus extended duration of thromboprophylaxis.
Wiegers HMG; Schaafsma M; Guman NAM; Zelisse HS; Mulder FI; Middeldorp S; van Es N; Mom CH
J Thromb Haemost; 2023 Feb; 21(2):294-302. PubMed ID: 36700503
[TBL] [Abstract][Full Text] [Related]
2. The risk of venous thromboembolism in surgically treated hip fracture: A retrospective cohort study of 5184 patients.
Beauchamp-Chalifour P; Belzile ÉL; Michael R; Langevin V; Gaudreau N; Normandeau N; Bédard L; Pelet S
Orthop Traumatol Surg Res; 2022 Feb; 108(1):103142. PubMed ID: 34775033
[TBL] [Abstract][Full Text] [Related]
3. Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery.
Felder S; Rasmussen MS; King R; Sklow B; Kwaan M; Madoff R; Jensen C
Cochrane Database Syst Rev; 2019 Aug; 8(8):CD004318. PubMed ID: 31449321
[TBL] [Abstract][Full Text] [Related]
4. Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery.
Felder S; Rasmussen MS; King R; Sklow B; Kwaan M; Madoff R; Jensen C
Cochrane Database Syst Rev; 2019 Mar; 3(3):CD004318. PubMed ID: 30916777
[TBL] [Abstract][Full Text] [Related]
5. Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.
Huo MH; Muntz J
Clin Ther; 2009 Jun; 31(6):1129-41. PubMed ID: 19695383
[TBL] [Abstract][Full Text] [Related]
6. Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery.
Felder S; Rasmussen MS; King R; Sklow B; Kwaan M; Madoff R; Jensen C
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD004318. PubMed ID: 30481366
[TBL] [Abstract][Full Text] [Related]
7. Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy.
Di Nisio M; Porreca E; Candeloro M; De Tursi M; Russi I; Rutjes AW
Cochrane Database Syst Rev; 2016 Dec; 12(12):CD008500. PubMed ID: 27906452
[TBL] [Abstract][Full Text] [Related]
8. Implementation of routine venous thromboembolism prophylaxis during neoadjuvant chemotherapy for patients with ovarian cancer.
McLaughlin HD; Greco P; Straubhar AM; Rolston A; McCool K; Brackmann M; Siedel JH; McLean K; Reynolds RK; Uppal S
Gynecol Oncol; 2023 Nov; 178():89-95. PubMed ID: 37832182
[TBL] [Abstract][Full Text] [Related]
9. Incidence of venous thromboembolism after standard treatment in patients with epithelial ovarian cancer in Korea.
Shin W; Lee S; Lim MC; Jung J; Kim HJ; Cho H
Cancer Med; 2021 Mar; 10(6):2045-2053. PubMed ID: 33638309
[TBL] [Abstract][Full Text] [Related]
10. Incidence of venous thromboembolism in patients with advanced stage ovarian cancer undergoing neoadjuvant chemotherapy: Is it time for thromboprophylaxis?
Shafa A; Watkins AB; McGree ME; Weroha SJ; Wahner Hendrickson AE; Block MS; Langstraat CL; McBane RD; Bakkum-Gamez JN; Kumar A
Gynecol Oncol; 2023 Sep; 176():36-42. PubMed ID: 37442024
[TBL] [Abstract][Full Text] [Related]
11. "Risk of venous thromboembolism and bleeding after major surgery for ovarian cancer: standard in-hospital versus extended duration of thromboprophylaxis": Comment.
Norris LA; Saadeh FA
J Thromb Haemost; 2023 Jun; 21(6):1681-1683. PubMed ID: 37179077
[No Abstract] [Full Text] [Related]
12. The value of extended preoperative thromboprophylaxis with dalteparin in patients with ovarian cancer qualified to surgical treatment.
Krasiński Z; Szpurek D; Staniszewski R; Dzieciuchowicz L; Pawlaczyk K; Krasińska B; Wójcicka K; Urbanek T
Int Angiol; 2014 Aug; 33(4):365-71. PubMed ID: 25056168
[TBL] [Abstract][Full Text] [Related]
13. Extended thromboprophylaxis following major abdominal/pelvic cancer-related surgery: A systematic review and meta-analysis of the literature.
Knoll W; Fergusson N; Ivankovic V; Wang TF; Caiano L; Auer R; Carrier M
Thromb Res; 2021 Aug; 204():114-122. PubMed ID: 34175749
[TBL] [Abstract][Full Text] [Related]
14. Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy.
Di Nisio M; Porreca E; Otten HM; Rutjes AW
Cochrane Database Syst Rev; 2014 Aug; (8):CD008500. PubMed ID: 25171736
[TBL] [Abstract][Full Text] [Related]
15. Incidence of venous thromboembolism, recurrence, and bleeding after isolated superficial vein thrombosis: findings from the Venous Thrombosis Registry in Østfold Hospital.
Jørgensen CT; Brækkan SK; Førsund E; Pettersen HH; Tjønnfjord E; Ghanima W; Tavoly M
J Thromb Haemost; 2024 Feb; 22(2):526-533. PubMed ID: 37913911
[TBL] [Abstract][Full Text] [Related]
16. Thromboprophylaxis in gynecologic cancer surgery: Is extended prophylaxis with low molecular weight heparin justified?
Marques de Marino P; Rial Horcajo R; Garcia Grandal T; Sanchez Hervas L; Serrano Hernando FJ; Herraiz Martinez MA; Coronado Martin PJ
Eur J Obstet Gynecol Reprod Biol; 2018 Nov; 230():90-95. PubMed ID: 30245443
[TBL] [Abstract][Full Text] [Related]
17. Event rates and risk factors for venous thromboembolism and major bleeding in a population of hospitalized adult patients with acute medical illness receiving enoxaparin thromboprophylaxis.
Gal GL; Agnelli G; Darius H; Kahn SR; Owaidah T; Rocha AT; Zhai Z; Khan I; Djoudi Y; Ponomareva E; Cohen AT
Eur J Intern Med; 2024 Mar; 121():48-55. PubMed ID: 38030465
[TBL] [Abstract][Full Text] [Related]
18. Incidence and predictors of venous thromboembolism after debulking surgery for epithelial ovarian cancer.
Mokri B; Mariani A; Heit JA; Weaver AL; McGree ME; Martin JR; Lemens MA; Cliby WA; Bakkum-Gamez JN
Int J Gynecol Cancer; 2013 Nov; 23(9):1684-91. PubMed ID: 24172104
[TBL] [Abstract][Full Text] [Related]
19. Incidence of venous thromboembolism and bleeding after pulmonary lobectomy: evaluating the timing for thromboprophylaxis.
Smith D; Raices M; Diego C; Julián D; Montagne J; Dietrich A
J Thromb Thrombolysis; 2021 May; 51(4):997-1004. PubMed ID: 32929687
[TBL] [Abstract][Full Text] [Related]
20. Incidence and determinants of thrombotic and bleeding complications in patients with glioblastoma.
Kaptein FHJ; Stals MAM; Kapteijn MY; Cannegieter SC; Dirven L; van Duinen SG; van Eijk R; Huisman MV; Klaase EE; Taphoorn MJB; Versteeg HH; Buijs JT; Koekkoek JAF; Klok FA
J Thromb Haemost; 2022 Jul; 20(7):1665-1673. PubMed ID: 35460331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
